Chemical Structure and Component Differences (Core Differences):** - **L-Arginine-L-Aspartic Acid:** Composed of L-arginine and L-aspartic acid. - **Carrier:** Arginine (provides amino groups and is a precursor for the urea cycle). - **Auxiliary:** Aspartic acid (helps transport ammonia, provides cellular energy, and protects liver cells). - **Aspartic Acid-Orcinine:** Forms a salt with L-ornithine and L-aspartic acid. - **Carrier:** Ornithine (the core component of the urea cycle). - **Auxiliary:** Aspartic acid (helps transport ammonia). Both compounds share the component “aspartic acid,” but the key basic amino acids are different: one is arginine and the other is ornithine. These differences directly determine the strength of the metabolic pathway, the focus of indications, and the appropriate patient populations. **II. Pharmacological Mechanisms of Ammonia Metabolism (Urea Cycle):** The urea cycle pathway: Ammonia + CO₂ → Citrulline → Arginine → Urea + Ornithine. - **L-Arginine-L-Aspartic Acid:** Supplementing arginine in the downstream of the cycle promotes the breakdown of arginine into urea and ornithine, thereby indirectly facilitating the urea cycle. - **Additional Roles of Arginine:** Arginine also produces nitric oxide (NO), which dilates visceral blood vessels and improves liver microcirculation. Aspartic acid enhances energy metabolism in liver cells and repairs liver damage. **Advantages:** It helps reduce ammonia levels, improves liver microcirculation, has antioxidant effects, and provides nutritional support for liver cells. **Aspartic Acid-Orcinine (the mainstream choice for liver protection and ammonia reduction):** Ornithine directly activates ornithine carbamoyltransferase, the rate-limiting enzyme in the urea cycle. It quickly captures ammonia in the blood and converts it into urea for excretion. Aspartic acid provides a nitrogen source and promotes glutamine synthesis, providing two pathways for ammonia reduction. **Advantages:** It reduces ammonia levels rapidly and is particularly effective in cases of hepatic encephalopathy with high ammonia levels. **III. Comparison of Clinical Indications:** - **L-Arginine-L-Aspartic Acid:** - Used for mild to moderate liver damage, chronic hepatitis, and liver cirrhosis as a supportive treatment. - Suitable for chronic hyperammonemia, fatigue, and elevated transaminase levels. - Recommended after surgery, during radiotherapy and chemotherapy, and in cases of malnutrition with poor liver microcirculation. - Also used in patients with portal hypertension and insufficient liver blood supply. - Helps with lactic acid accumulation after exercise and ammonia buildup in the body (in the nutritional context). **Role:** Long-term liver protection, improvement of liver circulation, and nutritional support for mild to moderate ammonia elevation. - **Aspartic Acid-Orcinine:** - Used for acute and chronic liver diseases with high ammonia levels (hepatitis, liver cirrhosis, fatty liver, drug-induced liver damage). - Core indication: Hepatic encephalopathy (all stages of hepatic coma) and prevention of high ammonia levels before and after surgery. - Also used for acute cases of severe liver disease and liver failure to rapidly reduce ammonia levels. **Role:** Emergency treatment for severe hyperammonemia and hepatic encephalopathy. **Jingjing Pharmaceutical has been deeply involved in the amino acid industry for over two decades, adhering to the philosophy of “harmony and precision.” The raw materials “L-Arginine-L-Aspartic Acid” and “Aspartic Acid-Orcinine,” crafted with meticulous quality, have become the preferred choices in clinical and health care settings.**